PNS386 PATIENT PREFERENCES IN THE MEDICAL PRODUCT LIFECYCLE: INITIAL RESULTS FROM THE IMI PREFER PUBLIC-PRIVATE PROJECT

Incorporating patient preferences into decision-making has become increasingly important in the goal to strengthen patient-centric healthcare. PREFER is a 5-year research project funded the Innovative Medicines Initiative (IMI), aiming to improve the integration of patient preferences throughout the medical product lifecycle MPLC. This phase of the project aimed to identify: 1) when patient preference (PP) studies can be most successful and...